An Assay to Identify and Classify Epimutagens
An Assay to Identify and Classify Epimutagens
批准号:
7655389
负责人:
David Ian Kingston Martin
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2011-07-31
关键词:
AffectAzacitidineBiological AssayBiological ModelsButyratesCarcinogensCell Culture TechniquesCell LineCell SeparationCell physiologyCellsChemical AgentsChemicalsClone CellsCloningCultured CellsDNADNA SequenceDetectionDevelopmentDiseaseDoseElementsEngineeringEnsureEnvironmental HealthEnvironmental ProtectionEpigenetic ProcessEthionineEukaryotaExhibitsFutureGene MutationGenerationsGenomeGenomicsGrantGreen Fluorescent ProteinsHealthHumanHuman DevelopmentLearningMalignant NeoplasmsMammalian CellMammalsMeasurementMeasuresMethodsMonitorMutagenesisMutagenicity TestsMutagensMutationOrganismPathway interactionsPilot ProjectsPlayPopulationReadingRegulationReporterReporter GenesReportingReproducibilityResearchRoleScreening procedureSiteSystemTechniquesTestingTranscriptional RegulationTransfectionTransgenesTransgenic OrganismsTrichostatin Abasedesignenvironmental agentenvironmental chemicalfollow-uppublic health relevanceresponsesodium arsenitesuccesstooltransgene expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal aims to develop a method to screen for chemical agents that disrupt epigenetic processes in mammalian cells. Epigenetics deals with heritable changes to the function of DNA that does not involve altered DNA sequence. In mammals and other multicellular organisms, most of the genome is kept in a silent transcriptional state by epigenetic mechanisms. Disruption of this silent state can have drastic effects, including developmental anomalies and cancer. Some chemicals are known to disrupt epigenetic silencing, but we have no comprehensive picture of the environmental agents that can act as "epimutagens". We hypothesize that there are many chemical epimutagens. In order to facilitate the discovery and study of these agents, we propose to develop a mammalian cell-based system that can screen for epimutagenic activity in mammalian cells. We will adapt a system that we have used extensively to study epigenetic silencing of transgenes in cultured cells. By selecting for cell clones that are sensitive to the disruption of epigenetic silencing by known epimutagens, we will derive a panel of cell lines that can be used to screen for epimutagenic activity in a manner analogous to the Ames test for mutagenicity. PUBLIC HEALTH RELEVANCE: Human development and disease are pervasively affected by epigenetic processes. There may be many environmental agents that are capable of disrupting epigenetic silencing and causing health effects, but we lack the means to readily identify them. We propose to develop a system that will permit screening of large numbers of chemicals for epigenetic effects. PUBLIC HEALTH RELEVANCE: The protection of humans from harmful environmental chemicals requires the existence of means to identify such compounds from among the millions of dietary and industrial chemicals to which people are exposed. Tests for mutagenic compounds-those that cause errors in the sequence of DNA and are therefore carcinogenic-have existed since the 1970s. Another class of potential carcinogen, however, the class of epimutagenic compounds, is currently undetectable; research into and regulation of such compounds is not a routine part of environmental health monitoring. We propose to develop tools for the detection and measurement of epimutagens, ultimately enabling environmental protections to be put in place.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0082573
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Jacobs JE, Wagner M, Dhahbi J, Boffelli D, Martin DI]
通讯作者:
Martin DI
A high-throughput screen for candidate agents that may reverse gamma-globin silen
-
批准号:7532720
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2009
-
负责人:David Ian Kingston Martin
-
依托单位:
A high-throughput screen for candidate agents that may reverse gamma-globin silen
-
批准号:7851313
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2009
-
负责人:David Ian Kingston Martin
-
依托单位:
An Assay to Identify and Classify Epimutagens
-
批准号:7441234
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2008
-
负责人:David Ian Kingston Martin
-
依托单位:
Diet, Epigenetic Events, And Cancer Prevention
-
批准号:6958770
-
项目类别:
-
资助金额:$31.62万
-
财政年份:2005
-
负责人:David Ian Kingston Martin
-
依托单位:
Diet, Epigenetic Events, And Cancer Prevention
-
批准号:7426862
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2005
-
负责人:David Ian Kingston Martin
-
依托单位:
Diet, Epigenetic Events, And Cancer Prevention
-
批准号:7628081
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2005
-
负责人:David Ian Kingston Martin
-
依托单位:
Epigenetic Suppression of the Obese Yellow Phenotype
-
批准号:7102832
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2005
-
负责人:David Ian Kingston Martin
-
依托单位:
Germline epimutation of hMLH1 as a factor in HNPCC
-
批准号:7076832
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2005
-
负责人:David Ian Kingston Martin
-
依托单位:
Germline epimutation of hMLH1 as a factor in HNPCC
-
批准号:6856870
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2005
-
负责人:David Ian Kingston Martin
-
依托单位:
Diet, Epigenetic Events, And Cancer Prevention
-
批准号:7238704
-
项目类别:
-
资助金额:$29.98万
-
财政年份:2005
-
负责人:David Ian Kingston Martin
-
依托单位:
DONOR CD8 EFFECTOR FUNCTION IN MARROW TRANSPLANTATION
-
批准号:2655283
-
项目类别:
-
资助金额:$22.44万
-
财政年份:1996
-
负责人:David Ian Kingston Martin
-
依托单位:
GLOBIN GENE REGULATION BY RC TRANSCRIPTION FACTOR GATA-1
-
批准号:3367944
-
项目类别:
-
资助金额:$18.1万
-
财政年份:1992
-
负责人:David Ian Kingston Martin
-
依托单位:
GLOBIN GENE REGULATION BY RC TRANSCRIPTION FACTOR GATA-1
-
批准号:3367943
-
项目类别:
-
资助金额:$18.12万
-
财政年份:1992
-
负责人:David Ian Kingston Martin
-
依托单位:
PLACEBO CONTROLLED STUDY OF LAMIVUDINE AND INTRON A IN CHRONIC HEPATITIS B
-
批准号:6118403
-
项目类别:
-
资助金额:$2.51万
-
财政年份:--
-
负责人:David Ian Kingston Martin
-
依托单位:
国内基金
海外基金
CRISPR/Cas9全基因组文库筛选Venetoclax/Azacitidine耐药关键基因及其机制研究
-
批准号:82100198
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:胡甜园
-
依托单位: